Skip to Main content Skip to Navigation
Journal articles

Combining F-18-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study

Antoine Girard 1, 2, * Pierre-Jean Le Reste 3 Alice Metais 3 Beatrice Carsin Nicol 3 Dan Cristian Chiforeanu 3 Elise Bannier 3, 4 Boris Campillo-Gimenez 2, 1 Anne Devillers 1 Xavier Palard-Novello 1, 2 Florence Le Jeune 1, 2
* Corresponding author
4 Empenn
INSERM - Institut National de la Santé et de la Recherche Médicale, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE
Abstract : Purpose We aimed to compare spatial extent of high-grade subregions detected with combined [F-18]-dihydroxyphenylalanine (F-18-DOPA) PET and MRI to the one provided by advanced multimodal MRI alone including Contrast-enhanced (CE) and Perfusion weighted imaging (PWI). Then, we compared the accuracy between imaging modalities, in a per biopsy analysis. Methods Participants with suspected diffuse glioma were prospectively included between June 2018 and September 2019. Volumes of high-grade subregions were delineated respectively on F-18-DOPA PET and MRI (CE and PWI). Up to three per-surgical neuronavigation-guided biopsies were performed per patient. Results Thirty-eight biopsy samples from sixteen participants were analyzed. Six participants (38%) had grade IV IDH wild-type glioblastoma, six (38%) had grade III IDH-mutated astrocytoma and four (24%) had grade II IDH-mutated gliomas. Three patients had intratumoral heterogeneity with coexisting high- and low-grade tumor subregions. High-grade volumes determined with combined F-18-DOPA PET/MRI (median of 1.7 [interquartile range (IQR) 0.0, 19.1] mL) were larger than with multimodal MRI alone (median 1.3 [IQR 0.0, 12.8] mL) with low overlap (median Dice's coefficient 0.24 [IQR 0.08, 0.59]). Delineation volumes were substantially increased in five (31%) patients. In a per biopsy analysis, combined F-18-DOPA PET/MRI detected high-grade subregions with an accuracy of 58% compared to 42% (p = 0.03) with CE MRI alone and 50% (p = 0.25) using multimodal MRI (CE + PWI). Conclusions The addition of F-18-DOPA PET to multimodal MRI (CE and PWI) enlarged the delineation volumes and enhanced overall accuracy for detection of high-grade subregions. Thus, combining F-18-DOPA with advanced MRI may improve treatment planning in newly diagnosed gliomas.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03412994
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Monday, November 22, 2021 - 4:19:12 PM
Last modification on : Tuesday, November 23, 2021 - 11:55:57 AM

Files

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2022-04-22

Please log in to resquest access to the document

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

Antoine Girard, Pierre-Jean Le Reste, Alice Metais, Beatrice Carsin Nicol, Dan Cristian Chiforeanu, et al.. Combining F-18-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study. Journal of Neuro-Oncology, Springer Verlag, 2021, ⟨10.1007/s11060-021-03873-w⟩. ⟨hal-03412994⟩

Share

Metrics

Record views

41